IDIOPATHIC PARKINSON DISEASE
Clinical trials for IDIOPATHIC PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for IDIOPATHIC PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets genetic form of Parkinson's in Early-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called NEU-411 in 150 people aged 40-80 with early Parkinson's disease who have a specific genetic profile linked to the LRRK2 pathway. Participants will be randomly assigned to receive either NEU-411 or a placebo for about a year, with an op…
Matched conditions: IDIOPATHIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Neuron23 Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New turkish questionnaire aims to better measure Parkinson's movement side effects
Knowledge-focused Recruiting nowThis study translates and tests a questionnaire called PDYS-26 for Turkish-speaking people with Parkinson's disease. The questionnaire measures how involuntary movements (dyskinesia) affect daily activities. About 130 participants will fill out the form along with other surveys t…
Matched conditions: IDIOPATHIC PARKINSON DISEASE
Sponsor: Izmir Bakircay University • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC